Mastocytoma: Topical corticosteroid treatment [6]

Journal of the European Academy of Dermatology and Venereology

Volumn 15, Issue 5, 2001, Pages 492-494

  Mateo, J R ^a  

^a HOSPITAL GENERAL DE SEGOVIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; CLOBETASOL PROPIONATE; CORTICOSTEROID; HISTAMINE; TRIAMCINOLONE;

CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; LETTER; MALE; MASTOCYTOMA; MASTOCYTOSIS; PRIORITY JOURNAL; REMISSION; SKIN BIOPSY; SURGICAL TECHNIQUE; URTICARIA PIGMENTOSA;

ADMINISTRATION, TOPICAL; CLOBETASOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; MASTOCYTOSIS; TREATMENT OUTCOME;

EID: 0034765411     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2001.t01-3-00340.x     Document Type: Letter

References (10)

1. Urticaria pigmentosa appearing as a solitary nodular lesion
2. The mastocytosis syndrome: Clinical and biological studies
3. The mast cell and mast cell disease
4. Diagnóstico, tratamiento y clasificación de la mastocitosis pediátrica. Estudio de 172 casos
5. The skin in mastocytosis
6. Solitary mastocytoma producing symptoms mimicking those of a seizure disorder
7. Solitary mastocytoma of the eyelid
8. Pediatric mastocytosis
9. Urticaria pigmentosa. Systemic evaluation, and successful treatment with topical steroid
10. Cutaneous mast cell depletion results from topical corticosteroid usage